World's Best Scientists 2026 revealed!
Peter M. Glazer

Peter M. Glazer

D-Index & Metrics

Molecular Biology

D-Index
89
Citations
23869
World Ranking
768
National Ranking
406

Peter M. Glazer publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Peter M. Glazer sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 321 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Peter M. Glazer D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter M. Glazer sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 89 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Peter M. Glazer is affiliated with Yale University in the United States. Their research spans multiple areas within biochemistry, genetics, molecular biology, and medicine, focusing particularly on molecular biology and oncology. The scientist has contributed extensively to the fields of biochemistry, genetics, and molecular biology, with a total of 110 publications, and medicine, with 57 publications.

Glazer's subfields of study include molecular biology, oncology, immunology, pulmonary and respiratory medicine, and genetics. The subdiscipline distribution shows a predominant focus on molecular biology with 94 publications, followed by oncology at 21 publications, immunology with 12, pulmonary and respiratory medicine with 8, and genetics with 7.

Their main research topics incorporate areas such as RNA interference and gene delivery, advanced biosensing and bioanalysis techniques, CRISPR and genetic engineering, DNA and nucleic acid chemistry, interferon and immune responses, RNA modifications and cancer, and PARP inhibition in cancer therapy. These topics highlight diverse expertise in gene editing technologies and cancer biology. The number of publications within these topics are as follows:

  • RNA Interference and Gene Delivery: 50
  • Advanced biosensing and bioanalysis techniques: 32
  • CRISPR and Genetic Engineering: 26
  • DNA and Nucleic Acid Chemistry: 18
  • Interferon and immune responses: 16
  • RNA modifications and cancer: 14
  • PARP inhibition in cancer therapy: 12

Recent significant publications by Glazer feature work published between 2020 and 2021 in prominent journals, including:

  • Oncometabolites suppress DNA repair by disrupting local chromatin signalling, 2020, Nature
  • The NIH Somatic Cell Genome Editing program, 2021, Nature
  • Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway, 2020, Cancer Research
  • Targeting the Hypoxic and Acidic Tumor Microenvironment with pH-Sensitive Peptides, 2021, Cells
  • Peptide Nucleic Acids and Gene Editing: Perspectives on Structure and Repair, 2020, Molecules

Frequent co-authors of Glazer include W. Mark Saltzman, Elias Quijano, Ranjit S. Bindra, Alexandra S. Piotrowski-Daspit, and Yanfeng Liu. These collaborations have resulted in repeated joint publications, with the highest count of 21 joint works with W. Mark Saltzman.

The scientist's research is often published in specialized venues, with the most frequent publication venues being:

  • Cancer Research (14 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (6 publications)
  • NAR Cancer (3 publications)
  • Nature (2 publications)
  • Neuron (2 publications)

Best Publications

  • MicroRNA silencing for cancer therapy targeted to the tumour microenvironment

    Christopher J. Cheng;Raman Bahal;Imran A. Babar;Zachary Pincus

  • Genetic Instability Induced by the Tumor Microenvironment

    Toni Y. Reynolds;Sara Rockwell;Peter M. Glazer

  • MicroRNA Regulation of DNA Repair Gene Expression in Hypoxic Stress

    Meredith E. Crosby;Ritu Kulshreshtha;Mircea Ivan;Peter M. Glazer

  • 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.

    Parker L. Sulkowski;Christopher D. Corso;Nathaniel D. Robinson;Susan E. Scanlon

  • Insulin-like Growth Factor-I Receptor Overexpression Mediates Cellular Radioresistance and Local Breast Cancer Recurrence after Lumpectomy and Radiation

    Bruce C. Turner;Bruce G. Haffty;Latha Narayanan;Jianling Yuan

  • FACILITATING OLIGONUCLEOTIDE DELIVERY : HELPING ANTISENSE DELIVER ON ITS PROMISE

    Alan M. Gewirtz;Cy A. Stein;Peter M. Glazer

  • Mutagenesis in Mammalian Cells Induced by Triple Helix Formation and Transcription-Coupled Repair

    Gan Wang;Michael M. Seidman;Peter M. Glazer

  • Down-Regulation of Rad51 and Decreased Homologous Recombination in Hypoxic Cancer Cells

    Ranjit S. Bindra;Paul J. Schaffer;Alice Meng;Jennifer Woo

  • Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

    Bruce G Haffty;Elizabeth Harrold;Atif J Khan;Pradip Pathare

  • Hypoxia-induced down-regulation of BRCA1 expression by E2Fs.

    Ranjit S. Bindra;Shannon L. Gibson;Alice Meng;Ulrica Westermark

  • Chronic Hypoxia Decreases Synthesis of Homologous Recombination Proteins to Offset Chemoresistance and Radioresistance

    Norman Chan;Marianne Koritzinsky;Helen Zhao;Helen Zhao;Ranjit Bindra

  • MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU

    Elena Favaro;Elena Favaro;Anassuya Ramachandran;Robert McCormick;Harriet Gee

  • Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells.

    Valia T. Mihaylova;Ranjit S. Bindra;Jianling Yuan;Denise Campisi

  • Triplex DNA: fundamentals, advances, and potential applications for gene therapy

    Phillip P. Chan;P. M. Glazer

  • Specific Mutations Induced by Triplex-Forming Oligonucleotides in Mice

    Karen M. Vasquez;Latha Narayanan;Peter M. Glazer

  • Targeted Mutagenesis in Mammalian Cells Mediated by Intracellular Triple Helix Formation

    Gan Wang;D. D. Levy;M. M. Seidman;P. M. Glazer

  • p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.

    Pamela A. Havre;Jianling Yuan;Lora Hedrick;Kathleen R. Cho

  • Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH

    Jianling Yuan;Latha Narayanan;Sara Rockwell;Peter M. Glazer

  • Targeted gene knockout mediated by triple helix forming oligonucleotides.

    A. Majumdar;A. Khorlin;N. Dyatkina;F.-L. M. Lin

  • Triplex forming oligonucleotides: sequence-specific tools for gene targeting

    Melissa P. Knauert;Peter M. Glazer

Frequent Co-Authors

W. Mark Saltzman
W. Mark Saltzman Yale University
Bruce G. Haffty
Bruce G. Haffty Rutgers, The State University of New Jersey
Michael M. Seidman
Michael M. Seidman National Institutes of Health
Robert G. Bristow
Robert G. Bristow University of Manchester
Karen M. Vasquez
Karen M. Vasquez The University of Texas at Austin
R. Michael Liskay
R. Michael Liskay Oregon Health & Science University
Donald M. Engelman
Donald M. Engelman Yale University
Frank J. Slack
Frank J. Slack Beth Israel Deaconess Medical Center
Tian Xu
Tian Xu Westlake University
Patrick Sung
Patrick Sung The University of Texas Health Science Center at San Antonio

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology can open the door to diverse career opportunities in healthcare and life sciences. Many students interested in this field also consider roles in nursing or allied health. For those with a science background, there are online accelerated nursing programs for non nurses, which allow individuals to transition into nursing and expand their clinical skills quickly.

If you are already an RN and want to advance your qualifications, you can consider the shortest rn to bsn program options that offer a fast-track route to a Bachelor of Science in Nursing, often in as little as six months. After earning your BSN, further specialization—such as becoming a nurse practitioner—is possible. Many wonder how long does it take to be a nurse practitioner; depending on the pathway, accelerated programs can lead to advanced practice roles within a short timeframe.

Certain specialties, like psychiatric nursing, are in high demand. If you're curious about earning potential, you can review psychiatric nurse practitioner salary figures by state to understand the financial rewards of this fulfilling career.

Best Scientists Citing Peter M. Glazer

Trending Scientists

Recently Published Articles